<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Financial Reports News</title> 
<link>http://www.mdlinx.com/pharma-news/news.cfm/newspage/1/spec_id/39/subspec_id/719</link> 
<description>Financial Reports</description> 
<language>en-us</language> 
<copyright>Copyright 2013 MDLinx, Inc.</copyright>



<item> 
<title><![CDATA[Valeant pharmaceuticals prices public offering of common shares]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4685156/?xml</link> 
<pubDate>6/19/2013</pubDate> 
<description><![CDATA[<b>Valeant Pharmaceuticals International</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4685156/?xml</guid>
</item> 

<item> 
<title><![CDATA[Transaction in own shares]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4685744/?xml</link> 
<pubDate>6/19/2013</pubDate> 
<description><![CDATA[<b>Shire</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4685744/?xml</guid>
</item> 

<item> 
<title><![CDATA[Bristol-myers squibb grants help k-12 educators bring science to life and help students explore their interests in the sciences and science-based careers]]></title> 
<link>http://www.mdlinx.com/pharma-news/news-article.cfm/4684565/?xml</link> 
<pubDate>6/19/2013</pubDate> 
<description><![CDATA[<b>Bristol Myers-Squibb</b>]]></description> 
<guid>http://www.mdlinx.com/pharma-news/news-article.cfm/4684565/?xml</guid>
</item> 
  


</channel> 
</rss>

